275 Manufacture of allogeneic, HLA-matched, TCR-edited T-cell therapy reactive against minor histocompatibility antigen 1 to treat acute myeloid leukemia in combination with CD34 HSCT with the potential for high potency and durability
| Autor: | Robert Keefe, Tim Mayall, Egidio Cofano, Marlyn Anguelov, Constantinos Panousis, Paola Sette |
|---|---|
| Rok vydání: | 2022 |
| Zdroj: | Regular and Young Investigator Award Abstracts. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|